India's Richest People 2026 edition · Source: Hurun India
Rank#163- Wealth
- ₹22,900 Cr
- Company
- Laurus Labs
2020 2019 #819 2018 #669
Current companies 5 active board seats
Past companies 3 historical roles
Total affiliations 8 Since Dec 2005
Shareholding value •••• Premium profile
About Satyanarayana Chava
Data last updated:
Satyanarayana Chava is a Whole-Time Director at Laurus Labs Limited (since 2006), Director at Laurus Bio Private Limited (since 2021) and Nominee Director at Immunoadoptive Cell Therapy Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, Life Sciences and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹7,157 Cr; the largest is Laurus Labs Limited at ₹6,868 Cr (FY 2026). Earlier, Satyanarayana Chava was a Director at Pharmaceuticals Export Promotion Council Of India (2018–2024) and Director at S3v Vascular Technologies Limited (2012–2015) and 1 more.
C Satyanarayana is #163 among India's richest people (2026), with wealth of ₹22,900 Cr.
DIN 00211921
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 31 Dec 2005
Oldest Company Age 21 yrs
Largest company Laurus Labs Limited · ₹6,868 Cr (FY 2026)
Combined revenue ₹7,157 Cr across 4 companies
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Laurus Labs Limited L24239AP2005PLC047518 | Whole-Time Director | 21 Jan 2006 | 2005 | ₹6,868 Cr (FY 2026) | Active |
 Laurus Bio Private Limited U02423KA2005PTC036770 | Director | 20 Jan 2021 | 2005 | ₹203 Cr (FY 2026) | Active |
 Immunoadoptive Cell Therapy Private Limited U74999MH2018PTC315497 | Nominee Director | 09 Dec 2021 | 2018 | ₹77.75 Cr (FY 2026) | Active |
 Chemiasoft Private Limited U72300TG2014PTC092281 | Director | 10 Jan 2014 | 2014 | ₹8.40 Cr (FY 2025) | Active |
 Krka Pharma Private Limited U21000TS2024FTC184449 | Director | 12 Apr 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pharmaceuticals Export Promotion Council Of India U24239TG2004NPL043058 | Director | 25 Apr 2018 | 2004 | ₹35.95 Cr (FY 2024) | Active |
 S3v Vascular Technologies Limited U33112KA2011PLC059915 | Director | 29 Jun 2012 | 2011 | ₹15.15 Cr (FY 2024) | Active |
| Nowpos M-Solutions Private Limited U72200TG2005PTC046163 | Director | 31 Dec 2005 | 2005 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satyanarayana Chava
Directorship timeline
Open interactive timeline →Laurus Bio Private Limited
Laurus Labs Limited
Nowpos M-Solutions Private Limited
Chemiasoft Private Limited
Premium access
Shareholding and investment profile for Satyanarayana Chava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyanarayana Chava
Satyanarayana Chava currently holds 5 directorships: Laurus Labs Limited (Whole-Time Director, since 21 Jan 2006, revenue ₹6,868 Cr (FY 2026)); Laurus Bio Private Limited (Director, since 20 Jan 2021, revenue ₹203 Cr (FY 2026)); Immunoadoptive Cell Therapy Private Limited (Nominee Director, since 09 Dec 2021, revenue ₹77.75 Cr (FY 2026)); Chemiasoft Private Limited (Director, since 10 Jan 2014, revenue ₹8.40 Cr (FY 2025)); Krka Pharma Private Limited (Director, since 12 Apr 2024).
Satyanarayana Chava was first appointed on 31 Dec 2005 as Director at Nowpos M-Solutions Private Limited. The most recent appointment on record is 12 Apr 2024 at Krka Pharma Private Limited.
The 4 current companies of Satyanarayana Chava that report revenue have a combined latest revenue of ₹7,157 Cr: Laurus Labs Limited ₹6,868 Cr (FY 2026); Laurus Bio Private Limited ₹203 Cr (FY 2026); Immunoadoptive Cell Therapy Private Limited ₹77.75 Cr (FY 2026); Chemiasoft Private Limited ₹8.40 Cr (FY 2025).
Satyanarayana Chava held 3 earlier board appointments: Pharmaceuticals Export Promotion Council Of India (Director, 25 Apr 2018 to 23 Dec 2024); S3v Vascular Technologies Limited (Director, 29 Jun 2012 to 07 Aug 2015); Nowpos M-Solutions Private Limited (Director, from 31 Dec 2005).
The current boards of Satyanarayana Chava's companies include Krishna Chaitanya Chava (Laurus Labs Limited), Ramesh Subrahmanian (Laurus Labs Limited), Ravindranath Kancherla (Laurus Labs Limited), Sekar Karnam (Laurus Labs Limited), Shekhar Chintamani Mande (Laurus Labs Limited), Soumya Chava (Laurus Labs Limited), among others.